Novo Nordisk Stock Climbs Over 4% In Friday Pre-Market- What's Going On?

Name: Novo Nordisk Stock Climbs Over 4% In Friday Pre-Market- What's Going On?
Uploaded: 2025-08-08T12:01:17+00:00
Duration: 1 min 6 s
Channel: Benzinga
Description: Shares of Novo Nordisk climbed 4.29% during Friday’s pre-market trading session, after rival Eli Lilly’s Phase 3 ATTAIN-1 trial for obesity drug, orforglipron, trailed the Danish drug giant’s semaglutide on Thursday.

Benzinga

1 year ago

Shares of Novo Nordisk climbed 4.29% during Friday’s pre-market trading session, after rival Eli Lilly’s Phase 3 ATTAIN-1 trial for obesity drug, orforglipron, trailed the Danish drug giant’s semaglutide on Thursday.